Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer

5409.0000 -24.00 (-0.44%)

NSE Sep 29, 2025 15:52 PM

Volume: 184.2K

Alkem Laboratories Ltd.

06 Aug 2022

5409.00

-0.44%

Alkem Labs (HOLD): Higher expenses and forex loss dent margins; cut to HOLD

Hold: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Q1 revenue declined 6% YoY (+4% QoQ) to Rs 25.7bn on a high base, and EBITDA dropped 66% on weak margins

Alkem Laboratories L.. has an average target of 5463.50 from 2 brokers.